Publication | Open Access
Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma
16
Citations
29
References
2021
Year
This study identified GNG12 as a potential biomarker for osteosarcoma prognosis, highlighting its potential as an immunotherapy target.
| Year | Citations | |
|---|---|---|
Page 1
Page 1